Patent · US Active

Inhibitors of serine proteases

US8440706B2 · kind B2 · utility

2Cited by
107References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 28, 2011
Grant dateMay 14, 2013
Priority date
Expiry dateFeb 28, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula I:or a pharmaceutically acceptable salt or mixtures thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.